<b>improvement in Cold-induced Raynaud's Syndrome with Administration of Ticlopidine Hydrochloride Detected by Tc-99m Dtpa Human Serum Albumin Scintigraphy</b>

Kaminaga Tatsuro; Takada Kouichi; Kutomi Kimiko; Imai Erika; Furui Shigeru

Issn Print: 0363-9762

Publication Date: 2002/02/01

Improvement in Cold-Induced Raynaud's Syndrome with Administration of Ticlopidine Hydrochloride Detected by Tc-99m DTPA Human Serum Albumin Scintigraphy

KAMINAGA TATSURO; TAKADA KOUICHI; KUTOMI KIMIKO; IMAI ERIKA; FURUI SHIGERU


		Checking for direct PDF access through Ovid

View on Journal Site

Excerpt

A 65-year-old woman with arteriosclerosis obliterans had Raynaud's syndrome of the left foot. After administration of ticlopidine hydrochloride, the symptoms disappeared. Tc-99m DTPA human serum albumin (HSA) scintigraphy was performed before and 8 months after the administration of ticlopidine hydrochloride. The former examination revealed a cold-induced decrease of blood flow, whereas the later examination showed improved blood flow after a cold-loading test in the left foot. Tc-99m HAS DTPA scintigraphy is a useful tool to evaluate and follow Raynaud's syndrome.


		Loading Related Articles